[S02DA03, antipyrine, The serum concentration of Phenytoin can be increased when it is combined with Antipyrine.]
[A14AA02, stanozolol, The therapeutic efficacy of Phenytoin can be increased when used in combination with Stanozolol.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Phenytoin.]
[L04AA27, fingolimod, The metabolism of Fingolimod can be decreased when combined with Phenytoin.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be decreased when used in combination with Phenytoin.]
[A02BX02, sucralfate, Sucralfate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01EC02, sulfadiazine, The serum concentration of Phenytoin can be increased when it is combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The serum concentration of Phenytoin can be increased when it is combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The serum concentration of Phenytoin can be increased when it is combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Phenytoin can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Phenytoin can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Phenytoin can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Phenytoin can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, The serum concentration of Phenytoin can be increased when it is combined with Sulindac.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Phenytoin is combined with Sulthiame.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Phenytoin.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be decreased when used in combination with Phenytoin.]
[M01AX04, apazone, The serum concentration of Phenytoin can be increased when it is combined with Azapropazone.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be decreased when it is combined with Phenytoin.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Phenytoin.]
[N05CD07, temazepam, The serum concentration of Phenytoin can be increased when it is combined with Temazepam.]
[L01CB02, teniposide, The serum concentration of Teniposide can be decreased when it is combined with Phenytoin.]
[B01AE07, dabigatran etexilate, The metabolism of Dabigatran etexilate can be decreased when combined with Phenytoin.]
[G03BA03, testosterone, The metabolism of Testosterone can be increased when combined with Phenytoin.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Phenytoin.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Tetracycline can be increased when combined with Phenytoin.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be increased when combined with Phenytoin.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Phenytoin.]
[N04BC07, apomorphine, The metabolism of Phenytoin can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of somnolence and peripheral neuropathy can be increased when Thalidomide is combined with Phenytoin.]
[R03DA07, theobromine, The serum concentration of Theobromine can be decreased when it is combined with Phenytoin.]
[R03DA04, theophylline, The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.]
[R06AD03, thiethylperazine, The serum concentration of Phenytoin can be increased when it is combined with Thiethylperazine.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be increased when combined with Phenytoin.]
[N05CA19, thiopental, The metabolism of Thiopental can be increased when combined with Phenytoin.]
[N05AB08, thioproperazine, The serum concentration of Phenytoin can be increased when it is combined with Thioproperazine.]
[N05AC02, thioridazine, The serum concentration of Phenytoin can be increased when it is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Phenytoin is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Phenytoin.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tiapride.]
[B01AC05, ticlopidine, The serum concentration of Phenytoin can be decreased when it is combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be increased when combined with Phenytoin.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be increased when combined with Phenytoin.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Phenytoin.]
[V04CA01, tolbutamide, The serum concentration of Phenytoin can be increased when it is combined with Tolbutamide.]
[M02AA21, tolmetin, The serum concentration of Phenytoin can be increased when it is combined with Tolmetin.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tolperisone.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Phenytoin.]
[N06AF04, tranylcypromine, The metabolism of Phenytoin can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The serum concentration of Phenytoin can be increased when it is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Phenytoin can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The serum concentration of Triamcinolone can be decreased when it is combined with Phenytoin.]
[N05CD05, triazolam, The metabolism of Triazolam can be increased when combined with Phenytoin.]
[A03AB12, mepenzolate, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, The serum concentration of Phenytoin can be increased when it is combined with Trifluoperazine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Trifluperidol.]
[N05AA05, triflupromazine, The serum concentration of Phenytoin can be increased when it is combined with Triflupromazine.]
[S01BA09, clobetasone, The serum concentration of Clobetasone can be decreased when it is combined with Phenytoin.]
[S01BA10, alclometasone, The serum concentration of Alclometasone can be decreased when it is combined with Phenytoin.]
[D07AC02, fluclorolone, The serum concentration of Fluclorolone can be decreased when it is combined with Phenytoin.]
[N04AA01, trihexyphenidyl, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The serum concentration of Mometasone can be decreased when it is combined with Phenytoin.]
[A03AA05, trimebutine, The metabolism of Trimebutine can be increased when combined with Phenytoin.]
[R06AD01, trimeprazine, The serum concentration of Phenytoin can be increased when it is combined with Alimemazine.]
[N03AC02, trimethadione, The metabolism of Phenytoin can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The serum concentration of Trimethoprim can be decreased when it is combined with Phenytoin.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Phenytoin.]
[R06AC04, tripelennamine, The metabolism of Phenytoin can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Triprolidine.]
[A03BB01, butylscopolamine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Phenytoin can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be increased when combined with Phenytoin.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Phenytoin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Phenytoin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be increased when combined with Phenytoin.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Phenytoin.]
[L02BX03, abiraterone, The metabolism of Abiraterone can be increased when combined with Phenytoin.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be increased when combined with Phenytoin.]
[J05AP03, boceprevir, The serum concentration of Boceprevir can be decreased when it is combined with Phenytoin.]
[J05AP02, telaprevir, The serum concentration of Phenytoin can be decreased when it is combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Phenytoin.]
[N03AX21, ezogabine, The serum concentration of Ezogabine can be decreased when it is combined with Phenytoin.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be increased when combined with Phenytoin.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be increased when combined with Phenytoin.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be increased when combined with Phenytoin.]
[C08DA01, verapamil, The serum concentration of Verapamil can be decreased when it is combined with Phenytoin.]
[N06AX09, viloxazine, The metabolism of Phenytoin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Phenytoin.]
[L01CA02, vincristine, The serum concentration of Vincristine can be decreased when it is combined with Phenytoin.]
[L01CA03, vindesine, The serum concentration of Phenytoin can be decreased when it is combined with Vindesine.]
[A11HA03, vitamin E, The metabolism of Vitamin E can be increased when combined with Phenytoin.]
[B01AA03, warfarin, The metabolism of Warfarin can be increased when combined with Phenytoin.]
[S01AA13, fusidic acid, The metabolism of Phenytoin can be decreased when combined with Fusidic acid.]
[J05AF01, zidovudine, The metabolism of Phenytoin can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Phenytoin.]
[J05AE02, indinavir, The serum concentration of Indinavir can be decreased when it is combined with Phenytoin.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Phenytoin is combined with Levetiracetam.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Phenytoin.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Pamidronic acid.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Phenytoin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be increased when combined with Phenytoin.]
[R03DC01, zafirlukast, The metabolism of Phenytoin can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Phenytoin can be decreased when combined with Rabeprazole.]
[H05BX03, doxercalciferol, The serum concentration of Doxercalciferol can be decreased when it is combined with Phenytoin.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ibandronate.]
[L01XX02, asparaginase, The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Escherichia coli.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be increased when combined with Phenytoin.]
[V03AC02, deferiprone, The serum concentration of Deferiprone can be increased when it is combined with Phenytoin.]
[N02BA01, aspirin, The serum concentration of Phenytoin can be increased when it is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Phenytoin.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be increased when combined with Phenytoin.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Phenytoin.]
[A11CC03, alfacalcidol, The serum concentration of Alfacalcidol can be decreased when it is combined with Phenytoin.]
[J02AC03, voriconazole, The serum concentration of Voriconazole can be decreased when it is combined with Phenytoin.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be decreased when used in combination with Phenytoin.]
[S01FA01, atropine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be increased when combined with Phenytoin.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Phenytoin.]
[R07AX02, ivacaftor, The serum concentration of Ivacaftor can be decreased when it is combined with Phenytoin.]
[H02AB11, prednylidene, The serum concentration of Prednylidene can be decreased when it is combined with Phenytoin.]
[J01CA09, azlocillin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Azlocillin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Phenytoin.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[A08AA11, lorcaserin, The metabolism of Phenytoin can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Phenytoin can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Phenytoin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Phenytoin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Phenytoin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Phenytoin.]
[L04AA31, teriflunomide, The metabolism of Phenytoin can be decreased when combined with Teriflunomide.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AA01, aldosterone, The serum concentration of Aldosterone can be decreased when it is combined with Phenytoin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Phenytoin.]
[N05CA04, barbital, The metabolism of Phenytoin can be increased when combined with Barbital.]
[J05AE04, nelfinavir, The serum concentration of Nelfinavir can be decreased when it is combined with Phenytoin.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Phenytoin is combined with Rasagiline.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be increased when combined with Phenytoin.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Mosapride.]
[N06DA02, donepezil, The metabolism of Donepezil can be increased when combined with Phenytoin.]
[N03AX22, perampanel, The serum concentration of Perampanel can be decreased when it is combined with Phenytoin.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be increased when combined with Phenytoin.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Phenytoin is combined with Zolmitriptan.]
[R06AC06, thonzylamine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Phenytoin can be decreased when combined with Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Phenytoin is combined with Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be increased when combined with Phenytoin.]
[G04BE03, sildenafil, The metabolism of Phenytoin can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Phenytoin.]
[B01AF02, apixaban, The metabolism of Phenytoin can be decreased when combined with Apixaban.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Phenytoin.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be increased when combined with Phenytoin.]
[C04AX11, bencyclane, The metabolism of Bencyclane can be increased when combined with Phenytoin.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be increased when combined with Phenytoin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Phenytoin can be decreased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Phenytoin.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be increased when combined with Phenytoin.]
[N02BA10, benorilate, The serum concentration of Phenytoin can be increased when it is combined with Benorilate.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Benperidol.]
[A10BK02, canagliflozin, The serum concentration of Canagliflozin can be decreased when it is combined with Phenytoin.]
[M04AB03, benzbromarone, The metabolism of Phenytoin can be decreased when combined with Benzbromarone.]
[A12CC09, magnesium orotate, Magnesium orotate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AX06, tegaserod, The metabolism of Phenytoin can be decreased when combined with Tegaserod.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Phenytoin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Benzocaine.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be decreased when used in combination with Phenytoin.]
[M01AH01, celecoxib, The serum concentration of Phenytoin can be increased when it is combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Phenytoin is combined with Naratriptan.]
[C10AC04, colesevelam, The serum concentration of Phenytoin can be decreased when it is combined with Colesevelam.]
[L04AA18, everolimus, The metabolism of Everolimus can be increased when combined with Phenytoin.]
[A12CC05, magnesium aspartate, Magnesium aspartate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04AC01, benztropine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Phenytoin can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The serum concentration of Phenytoin can be increased when it is combined with Benzydamine.]
[L01EE01, trametinib, The metabolism of Phenytoin can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Phenytoin.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be decreased when it is combined with Phenytoin.]
[C08EA02, bepridil, The metabolism of Bepridil can be increased when combined with Phenytoin.]
[C02KX05, riociguat, The metabolism of Phenytoin can be decreased when combined with Riociguat.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Phenytoin.]
[G03XC02, bazedoxifene, The serum concentration of Bazedoxifene can be decreased when it is combined with Phenytoin.]
[C02KX04, macitentan, The metabolism of Macitentan can be increased when combined with Phenytoin.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be increased when combined with Phenytoin.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Phenytoin.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be increased when combined with Phenytoin.]
[N03AF04, eslicarbazepine, The serum concentration of Eslicarbazepine can be decreased when it is combined with Phenytoin.]
[D01AC18, luliconazole, The serum concentration of Phenytoin can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Simeprevir can be increased when combined with Phenytoin.]
[N03AG04, vigabatrin, The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be increased when combined with Phenytoin.]
[C07AB04, acebutolol, The metabolism of Phenytoin can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Phenytoin.]
[A16AA07, metreleptin, The metabolism of Phenytoin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Phenytoin can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.]
[S01ED02, betaxolol, The metabolism of Phenytoin can be decreased when combined with Betaxolol.]
[V03AB34, fomepizole, The metabolism of Phenytoin can be decreased when combined with Fomepizole.]
[C10AB02, bezafibrate, The metabolism of Phenytoin can be decreased when combined with Bezafibrate.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be decreased when used in combination with Phenytoin.]
[L04AC11, siltuximab, The metabolism of Phenytoin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be increased when combined with Phenytoin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Phenytoin.]
[A03BA03, hyoscyamine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be increased when combined with Phenytoin.]
[L01XH04, belinostat, The metabolism of Belinostat can be increased when combined with Phenytoin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Phenytoin.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Alfaxalone.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Phenytoin.]
[R03AC19, olodaterol, The metabolism of Phenytoin can be decreased when combined with Olodaterol.]
[D11AA01, glycopyrronium, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be increased when combined with Phenytoin.]
[J01XA05, oritavancin, The metabolism of Phenytoin can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The serum concentration of Phenytoin can be increased when it is combined with Acepromazine.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Phenytoin.]
[A06AH03, naloxegol, The metabolism of Naloxegol can be increased when combined with Phenytoin.]
[N04AA02, biperiden, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be increased when combined with Phenytoin.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be increased when combined with Phenytoin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Phenytoin.]
[J05AP09, dasabuvir, The metabolism of Phenytoin can be decreased when combined with Dasabuvir.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Phenytoin.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Phenytoin.]
[N06AX11, mirtazapine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Phenytoin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Phenytoin.]
[L01XH03, panobinostat, The metabolism of Phenytoin can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be increased when combined with Phenytoin.]
[N02BE01, acetaminophen, Phenytoin may increase the hepatotoxic activities of Acetaminophen.]
[L01DC01, bleomycin, The serum concentration of Phenytoin can be decreased when it is combined with Bleomycin.]
[A03AA09, difemerine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, The metabolism of Ivabradine can be increased when combined with Phenytoin.]
[J05AP06, asunaprevir, The metabolism of Phenytoin can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be increased when combined with Phenytoin.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Phenytoin.]
[A04AD14, rolapitant, The metabolism of Phenytoin can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be increased when combined with Phenytoin.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be increased when combined with Phenytoin.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be decreased when used in combination with Phenytoin.]
[M02AA25, aceclofenac, The serum concentration of Phenytoin can be increased when it is combined with Aceclofenac.]
[M01AB11, acemetacin, The serum concentration of Phenytoin can be increased when it is combined with Acemetacin.]
[S01EC01, acetazolamide, The risk or severity of osteomalacia can be increased when Acetazolamide is combined with Phenytoin.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Phenytoin.]
[N05AB07, acetophenazine, The serum concentration of Phenytoin can be increased when it is combined with Acetophenazine.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Acipimox.]
[A02BC03, lansoprazole, The metabolism of Phenytoin can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Phenytoin.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be increased when combined with Phenytoin.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Phenytoin.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Phenytoin.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Phenytoin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Phenytoin.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Phenytoin.]
[B01AC27, selexipag, The metabolism of Phenytoin can be decreased when combined with Selexipag.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Phenytoin.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be increased when combined with Phenytoin.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Phenytoin.]
[L01XA04, satraplatin, Satraplatin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be increased when combined with Phenytoin.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be increased when combined with Phenytoin.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Aprobarbital.]
[M01AE16, alminoprofen, The serum concentration of Phenytoin can be increased when it is combined with Alminoprofen.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA02, aloxiprin, The protein binding of Phenytoin can be decreased when combined with Aloxiprin.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be increased when combined with Phenytoin.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Phenytoin.]
[N05BA08, bromazepam, The serum concentration of Phenytoin can be increased when it is combined with Bromazepam.]
[N04BC01, bromocriptine, The metabolism of Bromocriptine can be increased when combined with Phenytoin.]
[M05BX02, aluminum chlorohydrate, Aluminum chlorohydrate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Alverine.]
[D07AC11, amcinonide, The serum concentration of Amcinonide can be decreased when it is combined with Phenytoin.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dexbrompheniramine.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Amineptine.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Phenytoin.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Phenytoin.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Phenytoin is combined with Aniracetam.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Levobupivacaine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Phenytoin.]
[N07BC01, buprenorphine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The metabolism of Buspirone can be increased when combined with Phenytoin.]
[L01AB01, busulfan, The serum concentration of Busulfan can be decreased when it is combined with Phenytoin.]
[P01BE02, artemether, The metabolism of Artemether can be increased when combined with Phenytoin.]
[P01BE03, artesunate, The metabolism of Artesunate can be decreased when combined with Phenytoin.]
[M02AA03, clofezone, The metabolism of Phenytoin can be decreased when combined with Rabeprazole.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Butorphanol.]
[R06AX09, azatadine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Phenytoin can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Phenytoin.]
[L01EF02, ribociclib, The metabolism of Phenytoin can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The serum concentration of Phenytoin can be increased when it is combined with Balsalazide.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be decreased when it is combined with Phenytoin.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be increased when combined with Phenytoin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Beclamide.]
[N06BC01, caffeine, The serum concentration of Caffeine can be decreased when it is combined with Phenytoin.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be decreased when used in combination with Phenytoin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Oxybuprocaine.]
[H05BX05, calcifediol, The serum concentration of Calcifediol can be decreased when it is combined with Phenytoin.]
[D05AX03, calcitriol, The serum concentration of Calcitriol can be decreased when it is combined with Phenytoin.]
[J01XX08, linezolid, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Linezolid.]
[J05AF06, abacavir, The metabolism of Abacavir can be increased when combined with Phenytoin.]
[J05AE09, tipranavir, The serum concentration of Tipranavir can be decreased when it is combined with Phenytoin.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be increased when combined with Phenytoin.]
[L04AB02, infliximab, The metabolism of Phenytoin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Phenytoin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Phenytoin.]
[N04BD03, safinamide, The metabolism of Safinamide can be increased when combined with Phenytoin.]
[J01MA23, delafloxacin, The metabolism of Phenytoin can be increased when combined with Delafloxacin.]
[D01AC10, bifonazole, The metabolism of Phenytoin can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, The serum concentration of Phenytoin can be increased when it is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Phenytoin.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Phenytoin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Phenytoin.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Phenytoin.]
[C07AB07, bisoprolol, The metabolism of Bisoprolol can be increased when combined with Phenytoin.]
[J05AG03, efavirenz, The serum concentration of Efavirenz can be decreased when it is combined with Phenytoin.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Phenytoin.]
[N04AA11, bornaprine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Bromperidol.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be increased when combined with Phenytoin.]
[R03BA02, budesonide, The serum concentration of Budesonide can be decreased when it is combined with Phenytoin.]
[M01AB07, bumadizone, The serum concentration of Phenytoin can be increased when it is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Phenytoin.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Phenytoin can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Phenytoin is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be decreased when it is combined with Phenytoin.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be decreased when used in combination with Phenytoin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Capsaicin.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Phenytoin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Phenytoin is combined with Vinylbital.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Captopril.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be increased when combined with Phenytoin.]
[L02BB05, apalutamide, The serum concentration of Phenytoin can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The serum concentration of Phenytoin can be decreased when it is combined with Carbamazepine.]
[A03AA03, camylofine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Carbimazole.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Carbinoxamine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Phenytoin.]
[B02BX09, fostamatinib, The metabolism of Fostamatinib can be increased when combined with Phenytoin.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenytoin.]
[B02BX08, avatrombopag, The metabolism of Phenytoin can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The metabolism of Baricitinib can be increased when combined with Phenytoin.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be increased when combined with Phenytoin.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be increased when combined with Phenytoin.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Phenytoin.]
[H01CC03, elagolix, The metabolism of Phenytoin can be decreased when combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be increased when combined with Phenytoin.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Phenytoin.]
[A16AX14, migalastat, The metabolism of Migalastat can be increased when combined with Phenytoin.]
[N03AX17, stiripentol, The serum concentration of Phenytoin can be increased when it is combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Phenytoin can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be increased when combined with Phenytoin.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be increased when combined with Phenytoin.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Phenytoin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Phenytoin.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Phenytoin is combined with Carbromal.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Phenytoin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The serum concentration of Phenytoin can be increased when it is combined with Lornoxicam.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be decreased when it is combined with Phenytoin.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Phenytoin.]
[R03BB08, revefenacin, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be increased when combined with Phenytoin.]
[L04AA39, emapalumab, The metabolism of Phenytoin can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The serum concentration of Phenytoin can be decreased when it is combined with Carmustine.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be increased when combined with Phenytoin.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Phenytoin.]
[L01XJ03, glasdegib, The metabolism of Phenytoin can be decreased when combined with Glasdegib.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be increased when combined with Phenytoin.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be increased when combined with Phenytoin.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Cinitapride.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Phenytoin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Esketamine.]
[L04AA42, siponimod, The therapeutic efficacy of Siponimod can be decreased when used in combination with Phenytoin.]
[J01FA09, clarithromycin, The metabolism of Phenytoin can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Brexanolone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Phenytoin.]
[N05BA09, clobazam, The metabolism of Phenytoin can be decreased when combined with Clobazam.]
[D07AB21, clocortolone, The serum concentration of Clocortolone can be decreased when it is combined with Phenytoin.]
[H02AB14, cloprednol, The serum concentration of Cloprednol can be decreased when it is combined with Phenytoin.]
[N05BA22, cloxazolam, The serum concentration of Phenytoin can be increased when it is combined with Cloxazolam.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ubidecarenone.]
[C09CA06, candesartan, The metabolism of Phenytoin can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Phenytoin can be increased when combined with Etanercept.]
[A12CC06, magnesium lactate, Magnesium lactate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AB17, cortivazol, The serum concentration of Cortivazol can be decreased when it is combined with Phenytoin.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be decreased when it is combined with Phenytoin.]
[L01FX14, polatuzumab vedotin, The risk or severity of adverse effects can be decreased when Phenytoin is combined with Polatuzumab vedotin.]
[L01XX66, selinexor, The metabolism of Selinexor can be increased when combined with Phenytoin.]
[J01DB04, cefazolin, The protein binding of Phenytoin can be decreased when combined with Cefazolin.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be decreased when it is combined with Phenytoin.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Phenytoin.]
[J01DD01, cefotaxime, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Cefotaxime.]
[N05AA06, cyamemazine, The serum concentration of Phenytoin can be increased when it is combined with Cyamemazine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Phenytoin.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be increased when combined with Phenytoin.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be increased when combined with Phenytoin.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Phenytoin.]
[N07XX11, pitolisant, The metabolism of Pitolisant can be increased when combined with Phenytoin.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Phenytoin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Phenytoin.]
[N04CX01, istradefylline, The metabolism of Phenytoin can be decreased when combined with Istradefylline.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be increased when combined with Phenytoin.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Phenytoin.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Phenytoin.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Phenytoin.]
[J01DB03, cephalothin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Cefalotin.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be decreased when it is combined with Phenytoin.]
[G03DB05, demegestone, The metabolism of Demegestone can be increased when combined with Phenytoin.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Phenytoin.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Phenytoin.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Phenytoin.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be increased when combined with Phenytoin.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be decreased when it is combined with Phenytoin.]
[N03AX25, cenobamate, The serum concentration of Phenytoin can be increased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Phenytoin can be increased when it is combined with Givosiran.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be decreased when it is combined with Phenytoin.]
[L01FX13, enfortumab vedotin, The metabolism of Enfortumab vedotin can be increased when combined with Phenytoin.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dexbrompheniramine.]
[R06AB02, dexchlorpheniramine, The metabolism of Phenytoin can be decreased when combined with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, The serum concentration of Dexpanthenol can be decreased when it is combined with Phenytoin.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dezocine.]
[L01EX18, avapritinib, The metabolism of Phenytoin can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Phenytoin.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Phenytoin.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Phenytoin.]
[M01AX21, diacetylrhein, The metabolism of Phenytoin can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Phenytoin.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be decreased when it is combined with Phenytoin.]
[J05AE05, amprenavir, The metabolism of Phenytoin can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Phenytoin is combined with Frovatriptan.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be increased when combined with Phenytoin.]
[L04AA38, ozanimod, The metabolism of Phenytoin can be decreased when combined with Ozanimod.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be decreased when it is combined with Phenytoin.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Phenytoin.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Difenoxin.]
[D07AC19, difluprednate, The serum concentration of Difluprednate can be decreased when it is combined with Phenytoin.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be increased when combined with Phenytoin.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be increased when combined with Phenytoin.]
[M01AH02, rofecoxib, The serum concentration of Phenytoin can be increased when it is combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Phenytoin can be decreased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Phenytoin can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Phenytoin.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Valpromide.]
[L01AA02, chlorambucil, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Chlorambucil.]
[S03AA08, chloramphenicol, The serum concentration of Phenytoin can be increased when it is combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The serum concentration of Phenytoin can be increased when it is combined with Chlordiazepoxide.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be increased when combined with Phenytoin.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be decreased when it is combined with Phenytoin.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be increased when combined with Phenytoin.]
[A03AA08, dihexyverine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Phenytoin.]
[N04BX04, opicapone, The metabolism of Phenytoin can be decreased when combined with Opicapone.]
[D07XB03, fluprednidene, The serum concentration of Fluprednidene can be decreased when it is combined with Phenytoin.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be increased when combined with Phenytoin.]
[G04BD09, trospium, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The serum concentration of Phenytoin can be increased when it is combined with Droxicam.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be decreased when it is combined with Phenytoin.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Phenytoin.]
[S01BA14, loteprednol, The serum concentration of Loteprednol can be decreased when it is combined with Phenytoin.]
[M02AA27, dexketoprofen, The serum concentration of Phenytoin can be increased when it is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be increased when combined with Phenytoin.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Dyclonine.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be decreased when it is combined with Phenytoin.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be increased when combined with Phenytoin.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Phenytoin.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be decreased when it is combined with Phenytoin.]
[P01BB01, proguanil, The metabolism of Proguanil can be increased when combined with Phenytoin.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Phenytoin is combined with Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Phenytoin can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Phenytoin is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Phenytoin can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be decreased when it is combined with Phenytoin.]
[R06AB04, chlorpheniramine, The serum concentration of Phenytoin can be increased when it is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be increased when combined with Phenytoin.]
[A10BB02, chlorpropamide, Phenytoin may decrease the hypoglycemic activities of Chlorpropamide.]
[N05AF03, chlorprothixene, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be increased when combined with Phenytoin.]
[A11CC05, cholecalciferol, The metabolism of Phenytoin can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Etifoxine.]
[N02BA07, ethenzamide, The serum concentration of Phenytoin can be increased when it is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA03, choline salicylate, The protein binding of Phenytoin can be decreased when combined with Choline salicylate.]
[N06BX18, vinpocetine, The metabolism of Vinpocetine can be increased when combined with Phenytoin.]
[N05BA18, ethyl loflazepate, The serum concentration of Phenytoin can be increased when it is combined with Ethyl loflazepate.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be increased when combined with Phenytoin.]
[M01AB08, etodolac, The serum concentration of Phenytoin can be increased when it is combined with Etodolac.]
[M02AA06, etofenamate, The serum concentration of Phenytoin can be increased when it is combined with Etofenamate.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Phenytoin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Phenytoin.]
[L02BX04, relugolix, The serum concentration of Relugolix can be decreased when it is combined with Phenytoin.]
[J05AJ04, cabotegravir, The serum concentration of Cabotegravir can be decreased when it is combined with Phenytoin.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be increased when combined with Phenytoin.]
[P03AX07, abametapir, The serum concentration of Phenytoin can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The metabolism of Vericiguat can be decreased when combined with Phenytoin.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be decreased when it is combined with Phenytoin.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Febarbamate.]
[N03AX10, felbamate, The serum concentration of Phenytoin can be increased when it is combined with Felbamate.]
[M01AE05, fenbufen, The serum concentration of Phenytoin can be increased when it is combined with Fenbufen.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be decreased when it is combined with Phenytoin.]
[G04CB01, finasteride, The metabolism of Finasteride can be increased when combined with Phenytoin.]
[R03BA03, flunisolide, The serum concentration of Flunisolide can be decreased when it is combined with Phenytoin.]
[S02BA08, fluocinolone acetonide, The serum concentration of Fluocinolone acetonide can be decreased when it is combined with Phenytoin.]
[R03CC15, formoterol, The metabolism of Formoterol can be increased when combined with Phenytoin.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Phenytoin.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be increased when combined with Phenytoin.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Phenytoin.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Phenytoin is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Phenytoin can be increased when combined with Peginterferon alfa-2b.]
[B03AB10, ferric maltol, The metabolism of Ferric maltol can be decreased when combined with Phenytoin.]
[A02BA01, cimetidine, The serum concentration of Phenytoin can be increased when it is combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be increased when combined with Phenytoin.]
[L01XX73, sotorasib, The serum concentration of Sotorasib can be decreased when it is combined with Phenytoin.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Phenytoin.]
[S03AA07, ciprofloxacin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.]
[L01XA01, cisplatin, Cisplatin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AB04, citalopram, The metabolism of Citalopram can be increased when combined with Phenytoin.]
[H01AC07, somapacitan, The metabolism of Phenytoin can be decreased when combined with Somapacitan.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be decreased when it is combined with Phenytoin.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Phenytoin.]
[L04AA48, belumosudil, The serum concentration of Belumosudil can be decreased when it is combined with Phenytoin.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be increased when combined with Phenytoin.]
[L01XX74, belzutifan, The metabolism of Belzutifan can be increased when combined with Phenytoin.]
[L01EB10, mobocertinib, The serum concentration of Mobocertinib can be decreased when it is combined with Phenytoin.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be increased when combined with Phenytoin.]
[N02CD07, atogepant, The serum concentration of Atogepant can be decreased when it is combined with Phenytoin.]
[L04AA59, avacopan, The metabolism of Avacopan can be increased when combined with Phenytoin.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Clemastine.]
[M01AG01, mefenamic acid, The serum concentration of Phenytoin can be increased when it is combined with Mefenamic acid.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Phenytoin.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Phenytoin.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Phenytoin.]
[N06AX25, St. John's wort extract, The serum concentration of Phenytoin can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Phenytoin can be increased when it is combined with Asciminib.]
[L02BG06, exemestane, The metabolism of Exemestane can be increased when combined with Phenytoin.]
[J05AX10, maribavir, The serum concentration of Maribavir can be decreased when it is combined with Phenytoin.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Phenytoin.]
[D07AD01, clobetasol, The serum concentration of Clobetasol can be decreased when it is combined with Phenytoin.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be increased when combined with Phenytoin.]
[J04BA01, clofazimine, The metabolism of Phenytoin can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Clofibrate can be increased when combined with Phenytoin.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be increased when combined with Phenytoin.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be decreased when it is combined with Phenytoin.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Phenytoin.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Phenytoin.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Phenytoin.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be decreased when it is combined with Phenytoin.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Phenytoin.]
[A02BC08, vonoprazan, The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Phenytoin.]
[N03AX27, ganaxolone, The metabolism of Ganaxolone can be increased when combined with Phenytoin.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Clothiapine.]
[H01CC04, linzagolix, The serum concentration of Phenytoin can be increased when it is combined with Linzagolix.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be increased when combined with Phenytoin.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be increased when combined with Phenytoin.]
[A04AA02, granisetron, The metabolism of Granisetron can be increased when combined with Phenytoin.]
[J05AX31, lenacapavir, The metabolism of Lenacapavir can be increased when combined with Phenytoin.]
[L01XX77, adagrasib, The serum concentration of Adagrasib can be decreased when it is combined with Phenytoin.]
[N05AH02, clozapine, The serum concentration of Clozapine can be decreased when it is combined with Phenytoin.]
[L01EN04, futibatinib, The metabolism of Futibatinib can be increased when combined with Phenytoin.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be decreased when used in combination with Phenytoin.]
[A10BK06, sotagliflozin, The serum concentration of Sotagliflozin can be decreased when it is combined with Phenytoin.]
[N05BA13, halazepam, The serum concentration of Phenytoin can be increased when it is combined with Halazepam.]
[D07AC12, halometasone, The serum concentration of Halometasone can be decreased when it is combined with Phenytoin.]
[H01AC08, somatrogon, The metabolism of Phenytoin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Cocaine.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be decreased when it is combined with Phenytoin.]
[C02KB01, metyrosine, Phenytoin may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Phenytoin can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The serum concentration of Phenytoin can be increased when it is combined with Proquazone.]
[R05DA04, codeine, The metabolism of Codeine can be increased when combined with Phenytoin.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Phenytoin is combined with Hexafluronium.]
[M04AC01, colchicine, The metabolism of Colchicine can be increased when combined with Phenytoin.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A03AB10, hexocyclium, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[L04AA13, leflunomide, The metabolism of Phenytoin can be decreased when combined with Leflunomide.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Phenytoin is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Phenytoin is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be increased when combined with Phenytoin.]
[N02BA16, imidazole-2-hydroxybenzoate, The serum concentration of Phenytoin can be increased when it is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be decreased when used in combination with Phenytoin.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Phenytoin.]
[J01FA15, telithromycin, The metabolism of Phenytoin can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The serum concentration of Ciclesonide can be decreased when it is combined with Phenytoin.]
[B01AC10, indobufen, The serum concentration of Phenytoin can be increased when it is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Desloratadine.]
[J05AB14, valganciclovir, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Valganciclovir.]
[M01AH03, valdecoxib, The serum concentration of Phenytoin can be increased when it is combined with Valdecoxib.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Isometheptene.]
[N02CC05, almotriptan, The metabolism of Phenytoin can be decreased when combined with Almotriptan.]
[M01AH04, parecoxib, The serum concentration of Phenytoin can be increased when it is combined with Parecoxib.]
[J02AC02, itraconazole, The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.]
[N05BA10, ketazolam, The metabolism of Ketazolam can be increased when combined with Phenytoin.]
[M01AA06, kebuzone, The serum concentration of Phenytoin can be increased when it is combined with Kebuzone.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be increased when combined with Phenytoin.]
[L01EA01, imatinib, The metabolism of Imatinib can be increased when combined with Phenytoin.]
[J02AC04, posaconazole, The serum concentration of Posaconazole can be decreased when it is combined with Phenytoin.]
[A02BC05, esomeprazole, The serum concentration of Phenytoin can be increased when it is combined with Esomeprazole.]
[C08CA09, lacidipine, The metabolism of Lacidipine can be increased when combined with Phenytoin.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Phenytoin.]
[N03AX09, lamotrigine, The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Nafarelin.]
[S01BA03, cortisone, The serum concentration of Cortisone can be decreased when it is combined with Phenytoin.]
[N07BC04, lofexidine, The therapeutic efficacy of Phenytoin can be increased when used in combination with Lofexidine.]
[M01AB09, lonazolac, The serum concentration of Phenytoin can be increased when it is combined with Lonazolac.]
[R06AX13, loratadine, The metabolism of Phenytoin can be decreased when combined with Loratadine.]
[N05CD06, lormetazepam, The serum concentration of Phenytoin can be increased when it is combined with Lormetazepam.]
[H01AA02, cosyntropin, Tetracosactide may increase the hepatotoxic activities of Phenytoin.]
[M02AA31, loxoprofen, The serum concentration of Phenytoin can be increased when it is combined with Loxoprofen.]
[D05AX04, tacalcitol, The serum concentration of Tacalcitol can be decreased when it is combined with Phenytoin.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA11, manidipine, The metabolism of Phenytoin can be decreased when combined with Manidipine.]
[D05AX02, calcipotriene, The serum concentration of Calcipotriol can be decreased when it is combined with Phenytoin.]
[A03AA04, mebeverine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Medifoxamine.]
[S01BA08, medrysone, The serum concentration of Medrysone can be decreased when it is combined with Phenytoin.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Phenytoin.]
[H02AB15, meprednisone, The serum concentration of Meprednisone can be decreased when it is combined with Phenytoin.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Phenytoin.]
[R06AD04, methdilazine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, The metabolism of Cyclandelate can be increased when combined with Phenytoin.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Methoxyphenamine.]
[R06AE03, cyclizine, The metabolism of Phenytoin can be decreased when combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Cyclobarbital.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be increased when combined with Phenytoin.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Phenytoin is combined with Melperone.]
[J01FA03, midecamycin, The metabolism of Midecamycin can be increased when combined with Phenytoin.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be decreased when used in combination with Phenytoin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Phenytoin.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Phenytoin.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Minaprine.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be decreased when it is combined with Phenytoin.]
[N06AG02, moclobemide, The metabolism of Phenytoin can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Phenytoin can be decreased when combined with Modafinil.]
[R06AX02, cyproheptadine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be increased when combined with Phenytoin.]
[M02AA02, mofebutazone, The serum concentration of Phenytoin can be increased when it is combined with Mofebutazone.]
[M01AX22, morniflumate, The serum concentration of Phenytoin can be increased when it is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Phenytoin can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Cytarabine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be increased when combined with Phenytoin.]
[M01AH05, etoricoxib, The serum concentration of Phenytoin can be increased when it is combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Phenytoin can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dantrolene.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Phenytoin.]
[L01DB02, daunorubicin, The metabolism of Phenytoin can be increased when combined with Daunorubicin.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Phenytoin.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[M01AX01, nabumetone, The serum concentration of Phenytoin can be increased when it is combined with Nabumetone.]
[N05BA16, nordazepam, The serum concentration of Phenytoin can be increased when it is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be increased when combined with Phenytoin.]
[N06AX06, nefazodone, The metabolism of Phenytoin can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Niaprazine.]
[L02BB02, nilutamide, The metabolism of Phenytoin can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be increased when combined with Phenytoin.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be increased when combined with Phenytoin.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be decreased when it is combined with Phenytoin.]
[M03AC11, cisatracurium, Phenytoin may decrease the neuromuscular blocking activities of Cisatracurium.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Normethadone.]
[N06AB10, escitalopram, The serum concentration of Phenytoin can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be increased when combined with Phenytoin.]
[A07EC03, olsalazine, The serum concentration of Phenytoin can be increased when it is combined with Olsalazine.]
[N06AA01, desipramine, The metabolism of Phenytoin can be decreased when combined with Desipramine.]
[S01BA11, desonide, The serum concentration of Desonide can be decreased when it is combined with Phenytoin.]
[D07XC02, desoximetasone, The serum concentration of Desoximetasone can be decreased when it is combined with Phenytoin.]
[H02AA03, desoxycorticosterone, The serum concentration of Desoxycortone can be decreased when it is combined with Phenytoin.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be increased when combined with Phenytoin.]
[L01XA03, oxaliplatin, Oxaliplatin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AE12, oxaprozin, The serum concentration of Phenytoin can be increased when it is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The serum concentration of Phenytoin can be increased when it is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Phenytoin is combined with Oxiracetam.]
[N04AA08, dexetimide, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Phenytoin can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Phenytoin can be decreased when combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Phenytoin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be increased when combined with Phenytoin.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be increased when combined with Phenytoin.]
[N03AC01, paramethadione, The metabolism of Phenytoin can be decreased when combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dextromoramide.]
[N06AB05, paroxetine, The serum concentration of Paroxetine can be decreased when it is combined with Phenytoin.]
[B01AC04, clopidogrel, The metabolism of Phenytoin can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Diamorphine.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be decreased when it is combined with Phenytoin.]
[N05BA01, diazepam, The serum concentration of Phenytoin can be decreased when it is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Phenacemide.]
[V03AH01, diazoxide, The serum concentration of Phenytoin can be decreased when it is combined with Diazoxide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Phenol.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, The risk or severity of osteomalacia can be increased when Diclofenamide is combined with Phenytoin.]
[S01BC03, diclofenac, The serum concentration of Phenytoin can be increased when it is combined with Diclofenac.]
[A03AA07, dicyclomine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be increased when combined with Phenytoin.]
[A03AX04, pinaverium, The metabolism of Pinaverium can be increased when combined with Phenytoin.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be increased when combined with Phenytoin.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Pipamperone.]
[A03AB14, pipenzolate, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Phenytoin.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Phenytoin.]
[A08AA03, diethylpropion, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Diethylpropion.]
[L02AA01, diethylstilbestrol, The serum concentration of Diethylstilbestrol can be decreased when it is combined with Phenytoin.]
[C08CA03, isradipine, The metabolism of Isradipine can be increased when combined with Phenytoin.]
[D07XC04, diflucortolone, The serum concentration of Difluocortolone can be decreased when it is combined with Phenytoin.]
[A03AB11, poldine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The serum concentration of Phenytoin can be increased when it is combined with Diflunisal.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be increased when combined with Phenytoin.]
[C01AA05, digoxin, The serum concentration of Digoxin can be decreased when it is combined with Phenytoin.]
[C10AX09, ezetimibe, The metabolism of Ezetimibe can be increased when combined with Phenytoin.]
[L01XX24, pegaspargase, The therapeutic efficacy of Phenytoin can be increased when used in combination with Pegaspargase.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Phenytoin.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Phenytoin.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Hydromorphone.]
[A11CC02, dihydrotachysterol, The serum concentration of Dihydrotachysterol can be decreased when it is combined with Phenytoin.]
[J05AE08, atazanavir, The metabolism of Phenytoin can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Phenytoin can be decreased when combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Pramocaine.]
[D07AC18, prednicarbate, The serum concentration of Prednicarbate can be decreased when it is combined with Phenytoin.]
[C08DB01, diltiazem, The metabolism of Phenytoin can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Pridinol.]
[R06AB03, dimethindene, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Phenytoin can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Progabide.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be decreased when it is combined with Phenytoin.]
[N02BB04, propyphenazone, The serum concentration of Phenytoin can be increased when it is combined with Propyphenazone.]
[M01AB14, proglumetacin, The serum concentration of Phenytoin can be increased when it is combined with Proglumetacin.]
[C05CA03, diosmin, The metabolism of Phenytoin can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Proparacaine.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be decreased when it is combined with Phenytoin.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Diphenoxylate.]
[N05CD10, quazepam, The metabolism of Quazepam can be increased when combined with Phenytoin.]
[N06BA11, dexmethylphenidate, The serum concentration of Phenytoin can be increased when it is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Cisapride can be increased when combined with Phenytoin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be increased when combined with Phenytoin.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Remoxipride.]
[C01BA03, disopyramide, The serum concentration of Disopyramide can be decreased when it is combined with Phenytoin.]
[P03AA04, disulfiram, The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Phenytoin can be decreased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Phenytoin can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Phenytoin is combined with Riluzole.]
[N05AX08, risperidone, The metabolism of Risperidone can be increased when combined with Phenytoin.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be increased when combined with Phenytoin.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be increased when combined with Phenytoin.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be increased when combined with Phenytoin.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Phenytoin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Phenytoin.]
[J05AE07, fosamprenavir, The serum concentration of Phenytoin can be decreased when it is combined with Fosamprenavir.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be increased when combined with Phenytoin.]
[S01BC05, ketorolac, The serum concentration of Phenytoin can be increased when it is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be increased when combined with Phenytoin.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Phenytoin.]
[N02BA06, salsalate, The serum concentration of Phenytoin can be increased when it is combined with Salsalate.]
[R03AC12, salmeterol, The metabolism of Phenytoin can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Phenytoin can be decreased when combined with Domperidone.]
[C01CA04, dopamine, The risk or severity of hypotension can be increased when Phenytoin is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Phenytoin can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be increased when combined with Phenytoin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Phenytoin.]
[J01AA02, doxycycline, The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[N06AB06, sertraline, The serum concentration of Phenytoin can be increased when it is combined with Sertraline.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be increased when combined with Phenytoin.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be increased when combined with Phenytoin.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be decreased when it is combined with Phenytoin.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Sodium phosphate, monobasic.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be increased when combined with Phenytoin.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be decreased when it is combined with Phenytoin.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Phenytoin is combined with Sumatriptan.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Phenytoin.]
[H01AA01, corticotropin, The serum concentration of Corticotropin can be decreased when it is combined with Phenytoin.]
[M01AC02, tenoxicam, The serum concentration of Phenytoin can be increased when it is combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Phenytoin can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, The metabolism of Terodiline can be increased when combined with Phenytoin.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Phenytoin.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Phenytoin is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Thiopropazate.]
[G04BD01, emepronium, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Phenytoin.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Enalapril.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tofisopam.]
[M01AG02, tolfenamic acid, The serum concentration of Phenytoin can be increased when it is combined with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Phenytoin.]
[N03AX11, topiramate, The serum concentration of the active metabolites of Phenytoin can be increased when Phenytoin is used in combination with Topiramate.]
[L02BA02, toremifene, The metabolism of Toremifene can be increased when combined with Phenytoin.]
[C03CA04, torsemide, The metabolism of Phenytoin can be decreased when combined with Torasemide.]
[N05CD11, triazulenone, The serum concentration of Phenytoin can be increased when it is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Phenytoin is combined with Triclofos.]
[A03AB08, tridihexethyl, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[H02CA01, trilostane, The serum concentration of Trilostane can be decreased when it is combined with Phenytoin.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Trimethobenzamide.]
[N04AA12, tropatepine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Phenytoin.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Phenytoin is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Phenytoin.]
[S01GX10, epinastine, The metabolism of Epinastine can be increased when combined with Phenytoin.]
[N06AX16, venlafaxine, The metabolism of Phenytoin can be decreased when combined with Venlafaxine.]
[S01GA03, xylometazoline, The serum concentration of Phenytoin can be increased when it is combined with Xylometazoline.]
[C08CA12, mepirodipine, The metabolism of Barnidipine can be increased when combined with Phenytoin.]
[S01EA01, epinephrine, The metabolism of Phenytoin can be decreased when combined with Epinephrine.]
[B05XA12, zinc chloride, Zinc chloride can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B05XA18, zinc sulfate, Zinc sulfate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CF02, zolpidem, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The serum concentration of Phenytoin can be increased when it is combined with Zomepirac.]
[N03AX15, zonisamide, Phenytoin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Phenytoin.]
[N05CF01, zopiclone, The metabolism of Phenytoin can be decreased when combined with Zopiclone.]
[N05AX11, zotepine, The metabolism of Zotepine can be increased when combined with Phenytoin.]
[L01XA02, carboplatin, Carboplatin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C02AC02, guanfacine, The metabolism of Guanfacine can be increased when combined with Phenytoin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Iloprost.]
[C01BG01, moricizine, The serum concentration of Phenytoin can be increased when it is combined with Moricizine.]
[A11CC01, ergocalciferol, The serum concentration of Ergocalciferol can be decreased when it is combined with Phenytoin.]
[G02AB03, ergonovine, The metabolism of Ergometrine can be increased when combined with Phenytoin.]
[C04AE01, ergoloid mesylates, USP, The metabolism of Ergoloid mesylate can be increased when combined with Phenytoin.]
[N02CA02, ergotamine, The metabolism of Phenytoin can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The serum concentration of Phenytoin can be decreased when it is combined with Valproic acid.]
[S01AA17, erythromycin, The metabolism of Erythromycin can be increased when combined with Phenytoin.]
[N05CD04, estazolam, The metabolism of Estazolam can be increased when combined with Phenytoin.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be increased when combined with Phenytoin.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be increased when combined with Phenytoin.]
[G03CA03, estradiol, The serum concentration of Estradiol can be decreased when it is combined with Phenytoin.]
[L01XX11, estramustine, The metabolism of Estramustine can be increased when combined with Phenytoin.]
[G03CC06, estriol, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Estriol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Phenytoin.]
[J04AK02, ethambutol, The metabolism of Phenytoin can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The serum concentration of Fluticasone furoate can be decreased when it is combined with Phenytoin.]
[R03BA05, fluticasone, The serum concentration of Fluticasone can be decreased when it is combined with Phenytoin.]
[C10AA04, fluvastatin, The serum concentration of Fluvastatin can be decreased when it is combined with Phenytoin.]
[C01CA15, gepefrine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Gepefrine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Phenytoin.]
[D07AC21, halobetasol, The serum concentration of Ulobetasol can be decreased when it is combined with Phenytoin.]
[L02AA03, ethinyl estradiol, The serum concentration of Ethinylestradiol can be decreased when it is combined with Phenytoin.]
[N04AA05, profenamine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The serum concentration of Phenytoin can be increased when it is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Ethotoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The serum concentration of Phenytoin can be increased when it is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be increased when combined with Phenytoin.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Etidocaine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Etomidate.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Phenytoin.]
[N05AE03, sertindole, The metabolism of Sertindole can be increased when combined with Phenytoin.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Nizatidine.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Phenytoin.]
[R06AX12, terfenadine, The metabolism of Phenytoin can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Phenytoin can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Phenytoin.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Phenytoin.]
[C10AA03, pravastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Phenytoin.]
[M01CB01, gold sodium thiomalate, The metabolism of Phenytoin can be decreased when combined with Sodium aurothiomalate.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be increased when combined with Phenytoin.]
[P02CA03, albendazole, The serum concentration of the active metabolites of Albendazole can be reduced when Albendazole is used in combination with Phenytoin resulting in a loss in efficacy.]
[C08CA02, felodipine, The metabolism of Phenytoin can be decreased when combined with Felodipine.]
[C08EA01, fendiline, The metabolism of Fendiline can be increased when combined with Phenytoin.]
[N03AX26, fenfluramine, The serum concentration of Fenfluramine can be decreased when it is combined with Phenytoin.]
[M01AE04, fenoprofen, The serum concentration of Phenytoin can be increased when it is combined with Fenoprofen.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be increased when combined with Phenytoin.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Phenytoin.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be increased when combined with Phenytoin.]
[G04BD02, flavoxate, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Phenytoin.]
[N02BG04, floctafenine, The serum concentration of Phenytoin can be increased when it is combined with Floctafenine.]
[J02AC01, fluconazole, The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.]
[J02AX01, flucytosine, The serum concentration of Phenytoin can be increased when it is combined with Flucytosine.]
[H02AA02, fludrocortisone, The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.]
[D07XB01, flumethasone, The serum concentration of Flumethasone can be decreased when it is combined with Phenytoin.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be increased when used in combination with Phenytoin.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be increased when combined with Phenytoin.]
[D07AC08, fluocinonide, The serum concentration of Fluocinonide can be decreased when it is combined with Phenytoin.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Phenytoin is combined with Melitracen.]
[H02AB03, fluocortolone, The serum concentration of Fluocortolone can be decreased when it is combined with Phenytoin.]
[V03AZ01, ethanol, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, The serum concentration of Phenytoin can be increased when it is combined with Floxuridine.]
[S01CB05, fluorometholone, The serum concentration of Fluorometholone can be decreased when it is combined with Phenytoin.]
[L01BC02, fluorouracil, The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of Anticonvulsant Toxicity can be increased when Fluoxetine is combined with Phenytoin.]
[N05AF01, flupenthixol, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The serum concentration of Phenytoin can be increased when it is combined with Fluphenazine.]
[D07AC07, flurandrenolide, The serum concentration of Flurandrenolide can be decreased when it is combined with Phenytoin.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be increased when combined with Phenytoin.]
[S01BC04, flurbiprofen, The serum concentration of Phenytoin can be increased when it is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The metabolism of Fluspirilene can be increased when combined with Phenytoin.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Phenytoin.]
[V04CX02, folic acid, The serum concentration of Phenytoin can be decreased when it is combined with Folic acid.]
[L01BC03, tegafur, The serum concentration of Phenytoin can be increased when it is combined with Tegafur.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be decreased when used in combination with Phenytoin.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Furazolidone.]
[J05AE10, darunavir, The serum concentration of Phenytoin can be decreased when it is combined with Darunavir.]
[C03CA01, furosemide, Phenytoin may decrease the diuretic activities of Furosemide.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Alendronic acid.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Phenytoin is combined with Eszopiclone.]
[D10AX01, aluminum chloride, Aluminum chloride can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Phenytoin is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be increased when combined with Phenytoin.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be decreased when used in combination with Phenytoin.]
[C08DA02, gallopamil, The metabolism of Gallopamil can be increased when combined with Phenytoin.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ganciclovir.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Phenytoin is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Phenytoin can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Phenytoin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Phenytoin.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be decreased when it is combined with Phenytoin.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be decreased when used in combination with Phenytoin.]
[J05AG04, etravirine, The serum concentration of Etravirine can be decreased when it is combined with Phenytoin.]
[N03AD03, methsuximide, The serum concentration of Phenytoin can be increased when it is combined with Methsuximide.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be increased when combined with Phenytoin.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be increased when combined with Phenytoin.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be increased when combined with Phenytoin.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Phenytoin.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Phenytoin.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Phenytoin.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Glutethimide.]
[A06AX01, glycerin, The metabolism of Phenytoin can be increased when combined with Glycerin.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitroglycerin.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Phenytoin.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Phenytoin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Phenytoin.]
[C07AB09, esmolol, The metabolism of Phenytoin can be decreased when combined with Esmolol.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Phenytoin.]
[P01BX01, halofantrine, The metabolism of Phenytoin can be decreased when combined with Halofantrine.]
[D07AD02, halcinonide, The serum concentration of Halcinonide can be decreased when it is combined with Phenytoin.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Phenytoin.]
[N01AB01, halothane, The serum concentration of Phenytoin can be increased when it is combined with Halothane.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be increased when combined with Phenytoin.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Phenytoin.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Phenytoin is combined with Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Phenytoin.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Allobarbital.]
[M04AA01, allopurinol, The metabolism of Phenytoin can be decreased when combined with Allopurinol.]
[C09CA01, losartan, The metabolism of Phenytoin can be decreased when combined with Losartan.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Phenytoin.]
[B05CB03, magnesium citrate, Magnesium citrate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC03, magnesium gluconate, Magnesium gluconate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Phenytoin.]
[A07EC02, mesalamine, The serum concentration of Phenytoin can be increased when it is combined with Mesalazine.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be increased when combined with Phenytoin.]
[C08CA10, nilvadipine, The metabolism of Phenytoin can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The serum concentration of Phenytoin can be increased when it is combined with Nimesulide.]
[R05DA03, hydrocodone, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.]
[D07AC16, hydrocortisone aceponate, The serum concentration of Hydrocortisone aceponate can be decreased when it is combined with Phenytoin.]
[D07AB02, hydrocortisone butyrate, The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Phenytoin.]
[D07AB11, hydrocortisone probutate, The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Phenytoin.]
[S01XA07, aluminum potassium sulfate, Potassium alum can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BD06, propiverine, The metabolism of Propiverine can be increased when combined with Phenytoin.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Phenytoin is combined with Prothipendyl.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be increased when combined with Phenytoin.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[J04AB04, rifabutin, The metabolism of Phenytoin can be increased when combined with Rifabutin.]
[S01BA13, rimexolone, The serum concentration of Rimexolone can be decreased when it is combined with Phenytoin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Risedronic acid.]
[R02AX02, ibuprofen, The serum concentration of Phenytoin can be increased when it is combined with Ibuprofen.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Phenytoin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Phenytoin.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be increased when combined with Phenytoin.]
[N06AA02, imipramine, The metabolism of Phenytoin can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The serum concentration of Paclitaxel can be decreased when it is combined with Phenytoin.]
[R01AD07, tixocortol, The serum concentration of Tixocortol can be decreased when it is combined with Phenytoin.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tizanidine.]
[L01CE01, topotecan, Phenytoin may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, The metabolism of Indapamide can be increased when combined with Phenytoin.]
[S01BC01, indomethacin, The serum concentration of Phenytoin can be increased when it is combined with Indomethacin.]
[A16AX05, zinc acetate, Zinc acetate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CB02, zinc gluconate, Zinc gluconate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Phenytoin.]
[A03AA30, piperidolate, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Phenytoin can be decreased when combined with Sitagliptin.]
[V08AB02, iohexol, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be increased when combined with Phenytoin.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be increased when combined with Phenytoin.]
[R06AE01, buclizine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Phenytoin.]
[C10AA06, cerivastatin, The metabolism of Phenytoin can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Alprenolol.]
[V03AB01, ipecac, The metabolism of Ipecac can be increased when combined with Phenytoin.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Stavudine.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Phenytoin is combined with Iprindole.]
[N06AF05, iproniazid, The metabolism of Phenytoin can be decreased when combined with Iproniazid.]
[N05AA07, chlorproethazine, The serum concentration of Phenytoin can be increased when it is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Phenytoin is combined with Isocarboxazid.]
[P01AX06, atovaquone, The metabolism of Phenytoin can be decreased when combined with Atovaquone.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be increased when combined with Phenytoin.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Entacapone.]
[J04AC01, isoniazid, The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be decreased when used in combination with Phenytoin.]
[C01DA14, isosorbide mononitrate, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be increased when combined with Phenytoin.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be increased when combined with Phenytoin.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be increased when combined with Phenytoin.]
[A07BC02, kaolin, Kaolin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Phenytoin.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Phenytoin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Phenytoin can be decreased when combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be increased when combined with Phenytoin.]
[H02CA04, levoketoconazole, The metabolism of Phenytoin can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The serum concentration of Phenytoin can be increased when it is combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Phenytoin can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The serum concentration of Phenytoin can be increased when it is combined with Ketoprofen.]
[V03AC03, deferasirox, The serum concentration of Deferasirox can be decreased when it is combined with Phenytoin.]
[L04AA24, abatacept, The metabolism of Phenytoin can be increased when combined with Abatacept.]
[D10AX04, aluminum oxide, Aluminum oxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BC09, rotigotine, Phenytoin may increase the sedative activities of Rotigotine.]
[J01MB02, nalidixic acid, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The serum concentration of Phenytoin can be increased when it is combined with Tiaprofenic acid.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Gamolenic acid.]
[C07AG01, labetalol, The metabolism of Labetalol can be increased when combined with Phenytoin.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be increased when combined with Phenytoin.]
[N03AX18, lacosamide, The serum concentration of Lacosamide can be decreased when it is combined with Phenytoin.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be increased when combined with Phenytoin.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be increased when combined with Phenytoin.]
[N04BA01, levodopa, The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Lidocaine.]
[C08EX01, lidoflazine, The metabolism of Lidoflazine can be increased when combined with Phenytoin.]
[N06BA13, armodafinil, The metabolism of Phenytoin can be decreased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Phenytoin.]
[N02CA07, lisuride, The metabolism of Lisuride can be increased when combined with Phenytoin.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Lofepramine.]
[A07DA03, loperamide, The metabolism of Phenytoin can be decreased when combined with Loperamide.]
[N05BA06, lorazepam, The metabolism of Lorazepam can be increased when combined with Phenytoin.]
[C10AA02, lovastatin, The metabolism of Phenytoin can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Loxapine.]
[J01AA04, lymecycline, The metabolism of Lymecycline can be increased when combined with Phenytoin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be increased when combined with Phenytoin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be increased when combined with Phenytoin.]
[B05XA11, magnesium chloride, Magnesium chloride can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Phenytoin can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Phenytoin can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Mazindol.]
[P02CA01, mebendazole, The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Meclizine.]
[M02AA18, meclofenamic acid, The serum concentration of Phenytoin can be increased when it is combined with Meclofenamic acid.]
[N05BA03, medazepam, The serum concentration of Phenytoin can be increased when it is combined with Medazepam.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be decreased when it is combined with Phenytoin.]
[G03DB03, medrogestone, The serum concentration of Medrogestone can be decreased when it is combined with Phenytoin.]
[P01BC02, mefloquine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Mefloquine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Melatonin.]
[N06DX01, memantine, The metabolism of Phenytoin can be decreased when combined with Memantine.]
[N02AB02, meperidine, The serum concentration of Meperidine can be decreased when it is combined with Phenytoin.]
[C01CA11, mephentermine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Mephentermine.]
[N03AB04, mephenytoin, The metabolism of Phenytoin can be decreased when combined with Mephenytoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Meprobamate.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Meptazinol.]
[L02BG01, aminoglutethimide, The metabolism of Phenytoin can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The serum concentration of Phenytoin can be increased when it is combined with Mesoridazine.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be increased when combined with Phenytoin.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Phenytoin.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be increased when combined with Phenytoin.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Phenytoin.]
[N06BA03, methamphetamine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Metamfetamine.]
[A03AB07, methantheline, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Phenytoin is combined with Methapyrilene.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be increased when combined with Phenytoin.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Lamivudine.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Metharbital.]
[S01EC05, methazolamide, The risk or severity of osteomalacia can be increased when Methazolamide is combined with Phenytoin.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Phenytoin is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Phenytoin can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Methocarbamol.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Methohexital.]
[A11HA02, pyridoxine, The metabolism of Phenytoin can be increased when combined with Pyridoxine.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Phenytoin is combined with Ziconotide.]
[L04AX03, methotrexate, The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.]
[N05AA02, methotrimeprazine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[D05BA02, methoxsalen, The metabolism of Phenytoin can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be increased when combined with Phenytoin.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Methyldopa.]
[V04CG05, methylene blue, The serum concentration of Phenytoin can be increased when it is combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Methylergometrine can be increased when combined with Phenytoin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Phenytoin.]
[N06BA04, methylphenidate, The serum concentration of Phenytoin can be increased when it is combined with Methylphenidate.]
[H02AB04, methylprednisolone, The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.]
[D07AC14, methylprednisolone aceponate, The serum concentration of Methylprednisolone aceponate can be decreased when it is combined with Phenytoin.]
[N03AF03, rufinamide, The serum concentration of Phenytoin can be increased when it is combined with Rufinamide.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be increased when combined with Phenytoin.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Phenytoin is combined with Methyprylon.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Phenytoin.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Phenytoin.]
[C07AB02, metoprolol, The metabolism of Phenytoin can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The serum concentration of Metronidazole can be decreased when it is combined with Phenytoin.]
[V04CD01, metyrapone, The serum concentration of Metyrapone can be decreased when it is combined with Phenytoin.]
[C01BB02, mexiletine, The serum concentration of Mexiletine can be decreased when it is combined with Phenytoin.]
[N06AX03, mianserin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Mianserin.]
[S02AA13, miconazole, The serum concentration of Phenytoin can be increased when it is combined with Miconazole.]
[N02BB03, aminopyrine, The serum concentration of Phenytoin can be increased when it is combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Midazolam can be increased when combined with Phenytoin.]
[G03XB01, mifepristone, The serum concentration of Phenytoin can be increased when it is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Phenytoin can be decreased when combined with Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be increased when combined with Phenytoin.]
[L01XX23, mitotane, The metabolism of Phenytoin can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The metabolism of Phenytoin can be increased when combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Molindone.]
[L03AC01, aldesleukin, The metabolism of Phenytoin can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The serum concentration of Amiodarone can be decreased when it is combined with Phenytoin.]
[N06AA09, amitriptyline, The metabolism of Phenytoin can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Phenytoin can be decreased when combined with Morphine.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be increased when combined with Phenytoin.]
[L04AB05, certolizumab pegol, The metabolism of Phenytoin can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Phenytoin can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Phenytoin.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be increased when combined with Phenytoin.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be decreased when used in combination with Phenytoin.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Amobarbital.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be increased when combined with Phenytoin.]
[P01BA06, amodiaquine, The metabolism of Phenytoin can be decreased when combined with Amodiaquine.]
[G04CA04, silodosin, The metabolism of Silodosin can be increased when combined with Phenytoin.]
[R03BB01, ipratropium bromide, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[G03XC01, raloxifene, The metabolism of Phenytoin can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Phenytoin.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be increased when combined with Phenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Phenytoin.]
[N04BC04, ropinirole, The metabolism of Ropinirole can be increased when combined with Phenytoin.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Phenytoin is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Phenytoin can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be increased when combined with Phenytoin.]
[L04AC03, anakinra, The metabolism of Phenytoin can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The therapeutic efficacy of Phenytoin can be increased when used in combination with Nandrolone phenpropionate.]
[N06BA01, amphetamine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The serum concentration of Phenytoin can be increased when it is combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Phenytoin can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Phenytoin can be decreased when combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Phenytoin is combined with Tolcapone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Phenytoin.]
[L02BG04, letrozole, The metabolism of Letrozole can be increased when combined with Phenytoin.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Phenytoin is combined with Remifentanil.]
[A10BX02, repaglinide, The metabolism of Phenytoin can be decreased when combined with Repaglinide.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be increased when combined with Phenytoin.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Desvenlafaxine can be increased when combined with Phenytoin.]
[C09CA07, telmisartan, The metabolism of Phenytoin can be decreased when combined with Telmisartan.]
[M04AA03, febuxostat, The metabolism of Febuxostat can be increased when combined with Phenytoin.]
[H05BX02, paricalcitol, The serum concentration of Paricalcitol can be decreased when it is combined with Phenytoin.]
[C10AD02, niacin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Nialamide.]
[C08CA04, nicardipine, The metabolism of Phenytoin can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Phenytoin.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Phenytoin.]
[N07BA01, nicotine, The metabolism of Nicotine can be increased when combined with Phenytoin.]
[C08CA05, nifedipine, The serum concentration of Phenytoin can be increased when it is combined with Nifedipine.]
[M02AA17, niflumic acid, The serum concentration of Phenytoin can be increased when it is combined with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The serum concentration of Nimodipine can be decreased when it is combined with Phenytoin.]
[C08CA07, nisoldipine, The serum concentration of Nisoldipine can be decreased when it is combined with Phenytoin.]
[N05CD02, nitrazepam, The metabolism of Nitrazepam can be increased when combined with Phenytoin.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be increased when combined with Phenytoin.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitric Oxide.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitrofurantoin.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be increased when combined with Phenytoin.]
[N04BC05, pramipexole, Phenytoin may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Nomifensine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be increased when combined with Phenytoin.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Norfloxacin.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Phenytoin.]
[C02KX01, bosentan, The metabolism of Phenytoin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Phenytoin.]
[R05DA07, noscapine, The metabolism of Phenytoin can be decreased when combined with Noscapine.]
[G02CA02, nylidrin, The metabolism of Nylidrin can be increased when combined with Phenytoin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Phenytoin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The serum concentration of Phenytoin can be increased when it is combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Opipramol.]
[N02AA02, opium, The metabolism of Opium can be increased when combined with Phenytoin.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be increased when combined with Phenytoin.]
[P02BA02, oxamniquine, The metabolism of Phenytoin can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Phenytoin can be decreased when combined with Oxandrolone.]
[N05BA04, oxazepam, The serum concentration of Phenytoin can be increased when it is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be increased when combined with Phenytoin.]
[A14AA05, oxymetholone, The therapeutic efficacy of Phenytoin can be increased when used in combination with Oxymetholone.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be increased when combined with Phenytoin.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, The serum concentration of Phenytoin can be increased when it is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[J04AA01, aminosalicylic acid, The protein binding of Phenytoin can be decreased when combined with Aminosalicylic acid.]
[N05AH05, asenapine, The metabolism of Asenapine can be increased when combined with Phenytoin.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Phenytoin.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be increased when combined with Phenytoin.]
[N05CC05, paraldehyde, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The serum concentration of Paramethasone can be decreased when it is combined with Phenytoin.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Phenytoin is combined with Pargyline.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be increased when combined with Phenytoin.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Penbutolol.]
[N05AG03, penfluridol, The metabolism of Penfluridol can be increased when combined with Phenytoin.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Penicillamine.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Pentazocine.]
[N05CA01, pentobarbital, The metabolism of Phenytoin can be increased when combined with Pentobarbital.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be decreased when it is combined with Phenytoin.]
[N05AB10, perazine, The serum concentration of Phenytoin can be increased when it is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Phenytoin can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The serum concentration of Phenytoin can be increased when it is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be increased when combined with Phenytoin.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Phenazocine.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Phenazopyridine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Phenelzine.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be decreased when used in combination with Phenytoin.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Phenoperidine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be increased when combined with Phenytoin.]
[A08AA01, phentermine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Phentermine.]
[M02AA01, phenylbutazone, The serum concentration of Phenytoin can be increased when it is combined with Phenylbutazone.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be increased when combined with Phenytoin.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Phenylpropanolamine.]
[N07XX04, sodium oxybate, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AB06, golimumab, The metabolism of Phenytoin can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Phenytoin.]
[C08CX01, mibefradil, The metabolism of Mibefradil can be increased when combined with Phenytoin.]
[S01EB01, pilocarpine, The metabolism of Phenytoin can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Phenytoin.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Phenytoin is combined with Pindolol.]
[C10AA05, atorvastatin, The serum concentration of Atorvastatin can be decreased when it is combined with Phenytoin.]
[J05AE01, saquinavir, The serum concentration of Saquinavir can be decreased when it is combined with Phenytoin.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Phenytoin.]
[N05AC04, pipothiazine, The serum concentration of Phenytoin can be increased when it is combined with Pipotiazine.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Eprosartan.]
[A02BX03, pirenzepine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Phenytoin is combined with Piritramide.]
[S01BC06, piroxicam, The serum concentration of Phenytoin can be increased when it is combined with Piroxicam.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be increased when combined with Phenytoin.]
[N02CX01, pizotyline, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The serum concentration of Delavirdine can be decreased when it is combined with Phenytoin.]
[C09CA04, irbesartan, The metabolism of Phenytoin can be decreased when combined with Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Phenytoin is combined with Proxibarbal.]
[D05AX05, tazarotene, The metabolism of Phenytoin can be decreased when combined with Tazarotene.]
[A10BG02, rosiglitazone, The metabolism of Phenytoin can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Phenytoin can be decreased when combined with Anastrozole.]
[A03AE01, alosetron, The metabolism of Alosetron can be increased when combined with Phenytoin.]
[L04AC08, canakinumab, The metabolism of Phenytoin can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Ritonavir can be decreased when it is combined with Phenytoin.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be increased when combined with Phenytoin.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Phenytoin.]
[C10AA08, pitavastatin, The metabolism of Phenytoin can be decreased when combined with Pitavastatin.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Phenytoin.]
[N05BA11, prazepam, The metabolism of Prazepam can be increased when combined with Phenytoin.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Phenytoin.]
[S03BA02, prednisolone, The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.]
[H02AB07, prednisone, The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.]
[C01DX02, prenylamine, The metabolism of Prenylamine can be increased when combined with Phenytoin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Phenytoin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Primidone can be increased when combined with Phenytoin.]
[M04AB01, probenecid, The metabolism of Phenytoin can be increased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Phenytoin.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Phenytoin.]
[N05AB04, prochlorperazine, The serum concentration of Phenytoin can be increased when it is combined with Prochlorperazine.]
[N04AA04, procyclidine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be increased when combined with Phenytoin.]
[N05AA03, promazine, The serum concentration of Phenytoin can be increased when it is combined with Promazine.]
[G03DB07, promegestone, The metabolism of Promegestone can be increased when combined with Phenytoin.]
[R06AD02, promethazine, The serum concentration of Phenytoin can be increased when it is combined with Promethazine.]
[C01BC03, propafenone, The metabolism of Propafenone can be increased when combined with Phenytoin.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Phenytoin is combined with Propanidid.]
[A03AB05, propantheline, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The serum concentration of Phenytoin can be increased when it is combined with Periciazine.]
[N05CM06, propiomazine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Phenytoin.]
[N01AX10, propofol, The metabolism of Phenytoin can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be increased when combined with Phenytoin.]
[C07AA05, propranolol, The serum concentration of Propranolol can be decreased when it is combined with Phenytoin.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Propylthiouracil.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Phenytoin is combined with Rizatriptan.]
[R03DC03, montelukast, The metabolism of Phenytoin can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Phenytoin is combined with Protriptyline.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Pseudoephedrine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Phenytoin.]
[A03AB15, diphemanil, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Phenytoin is combined with Talbutal.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Phenytoin is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Phenytoin is combined with Styramate.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be decreased when used in combination with Phenytoin.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Phenytoin is combined with Mepyramine.]
[P01BD01, pyrimethamine, The metabolism of Phenytoin can be decreased when combined with Pyrimethamine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be increased when combined with Phenytoin.]
[C01BA01, quinidine, The serum concentration of Quinidine can be decreased when it is combined with Phenytoin.]
[P01BC01, quinine, The serum concentration of Quinine can be decreased when it is combined with Phenytoin.]
[D07AC10, diflorasone, The serum concentration of Diflorasone can be decreased when it is combined with Phenytoin.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ranitidine.]
[C02AA02, reserpine, The serum concentration of Phenytoin can be decreased when it is combined with Reserpine.]
[J04AB02, rifampin, The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Phenytoin is combined with Oxitriptan.]
[J01FA06, roxithromycin, The metabolism of Roxithromycin can be increased when combined with Phenytoin.]
[A16AA02, S-adenosylmethionine, The metabolism of Phenytoin can be decreased when combined with Ademetionine.]
[N02BA05, salicylamide, The serum concentration of Phenytoin can be increased when it is combined with Salicylamide.]
[A07EC01, sulfasalazine, The serum concentration of Phenytoin can be increased when it is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The serum concentration of Phenytoin can be increased when it is combined with Salicylic acid.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be increased when combined with Phenytoin.]
[N05CA06, secobarbital, The metabolism of Phenytoin can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Phenytoin can be decreased when combined with Selegiline.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Phenytoin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Phenytoin.]
[C03DA01, spironolactone, The metabolism of Phenytoin can be decreased when combined with Spironolactone.]
